| ELAN CORP. |
| Japan |
| Gesundheit |
| JP3167680002 / A12C13 |
| 25E (Frankfurt) |
| FRA:25E, ETR:25E, 25E:GR |
| - |
| https://www.kkelan.com/ |
|
Elan Corporation plc, an Irish pharmaceutical company, primarily focused on the development and commercialization of biopharmaceutical treatments for neurodegenerative diseases, autoimmune disorders, and severe pain. Established in 1969, Elan gained ..
>Volltext.. |
| 242.53 Mio. EUR |
| 211.36 Mio. EUR |
| 306.52 Mio. EUR |
| 31.08 Mio. EUR |
| 15.3 Mio. EUR |
| 0.25 EUR |
| 4.79 Mio. EUR |
| 37.71 Mio. EUR |
| - |
| 0.62 |
| 3.2% |
| 3.95% |
| 0.08 EUR |
| 2.07% |
| 2.34% |
| 29.12.25 - 0.081552€ 27.12.24 - 0.0740688€ >weitere anzeigen... |
| - |
| ELAN CORP, ELAN CORPORATION |
| 05.04.26 |
|